nodes	percent_of_prediction	percent_of_DWPC	metapath
Fenoldopam—Oliguria—Mechlorethamine—lymphatic system cancer	0.0421	0.0421	CcSEcCtD
Fenoldopam—Transaminases increased—Carmustine—lymphatic system cancer	0.0265	0.0265	CcSEcCtD
Fenoldopam—Haemoglobin—Mechlorethamine—lymphatic system cancer	0.0196	0.0196	CcSEcCtD
Fenoldopam—Haemorrhage—Mechlorethamine—lymphatic system cancer	0.0195	0.0195	CcSEcCtD
Fenoldopam—Cardiac failure—Fludarabine—lymphatic system cancer	0.0187	0.0187	CcSEcCtD
Fenoldopam—Myocardial ischaemia—Mitoxantrone—lymphatic system cancer	0.0186	0.0186	CcSEcCtD
Fenoldopam—Leukocytosis—Carmustine—lymphatic system cancer	0.0171	0.0171	CcSEcCtD
Fenoldopam—Injection site reaction—Carmustine—lymphatic system cancer	0.016	0.016	CcSEcCtD
Fenoldopam—Angina pectoris—Fludarabine—lymphatic system cancer	0.0154	0.0154	CcSEcCtD
Fenoldopam—Sweating—Teniposide—lymphatic system cancer	0.0154	0.0154	CcSEcCtD
Fenoldopam—Haemoglobin—Teniposide—lymphatic system cancer	0.0144	0.0144	CcSEcCtD
Fenoldopam—Haemorrhage—Teniposide—lymphatic system cancer	0.0144	0.0144	CcSEcCtD
Fenoldopam—Blood urea increased—Mitoxantrone—lymphatic system cancer	0.0141	0.0141	CcSEcCtD
Fenoldopam—Acute coronary syndrome—Fludarabine—lymphatic system cancer	0.0139	0.0139	CcSEcCtD
Fenoldopam—Myocardial infarction—Fludarabine—lymphatic system cancer	0.0138	0.0138	CcSEcCtD
Fenoldopam—Urinary tract infection—Fludarabine—lymphatic system cancer	0.0137	0.0137	CcSEcCtD
Fenoldopam—Flushing—Teniposide—lymphatic system cancer	0.0133	0.0133	CcSEcCtD
Fenoldopam—Haemoglobin—Fludarabine—lymphatic system cancer	0.0127	0.0127	CcSEcCtD
Fenoldopam—Haemorrhage—Fludarabine—lymphatic system cancer	0.0126	0.0126	CcSEcCtD
Fenoldopam—Cardiac failure—Mitoxantrone—lymphatic system cancer	0.0111	0.0111	CcSEcCtD
Fenoldopam—Chest pain—Teniposide—lymphatic system cancer	0.0107	0.0107	CcSEcCtD
Fenoldopam—Hypokalaemia—Carmustine—lymphatic system cancer	0.0106	0.0106	CcSEcCtD
Fenoldopam—Blood creatinine increased—Mitoxantrone—lymphatic system cancer	0.0102	0.0102	CcSEcCtD
Fenoldopam—Acute coronary syndrome—Bleomycin—lymphatic system cancer	0.0102	0.0102	CcSEcCtD
Fenoldopam—Myocardial infarction—Bleomycin—lymphatic system cancer	0.0101	0.0101	CcSEcCtD
Fenoldopam—Tachycardia—Teniposide—lymphatic system cancer	0.00997	0.00997	CcSEcCtD
Fenoldopam—Hypokalaemia—Mitoxantrone—lymphatic system cancer	0.00989	0.00989	CcSEcCtD
Fenoldopam—Hyperhidrosis—Teniposide—lymphatic system cancer	0.00987	0.00987	CcSEcCtD
Fenoldopam—Hypotension—Teniposide—lymphatic system cancer	0.00954	0.00954	CcSEcCtD
Fenoldopam—Diarrhoea—Mechlorethamine—lymphatic system cancer	0.00948	0.00948	CcSEcCtD
Fenoldopam—Haemoglobin—Bleomycin—lymphatic system cancer	0.00931	0.00931	CcSEcCtD
Fenoldopam—Haemorrhage—Bleomycin—lymphatic system cancer	0.00926	0.00926	CcSEcCtD
Fenoldopam—Dyspnoea—Teniposide—lymphatic system cancer	0.00911	0.00911	CcSEcCtD
Fenoldopam—Vomiting—Mechlorethamine—lymphatic system cancer	0.00881	0.00881	CcSEcCtD
Fenoldopam—Urinary tract infection—Carmustine—lymphatic system cancer	0.00876	0.00876	CcSEcCtD
Fenoldopam—Hyperhidrosis—Fludarabine—lymphatic system cancer	0.00868	0.00868	CcSEcCtD
Fenoldopam—Flushing—Bleomycin—lymphatic system cancer	0.0086	0.0086	CcSEcCtD
Fenoldopam—Acute coronary syndrome—Vincristine—lymphatic system cancer	0.00848	0.00848	CcSEcCtD
Fenoldopam—Myocardial infarction—Vincristine—lymphatic system cancer	0.00843	0.00843	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Teniposide—lymphatic system cancer	0.00835	0.00835	CcSEcCtD
Fenoldopam—Acute coronary syndrome—Mitoxantrone—lymphatic system cancer	0.00826	0.00826	CcSEcCtD
Fenoldopam—Sweating—Vincristine—lymphatic system cancer	0.00824	0.00824	CcSEcCtD
Fenoldopam—Nausea—Mechlorethamine—lymphatic system cancer	0.00823	0.00823	CcSEcCtD
Fenoldopam—Myocardial infarction—Mitoxantrone—lymphatic system cancer	0.00821	0.00821	CcSEcCtD
Fenoldopam—Urinary tract infection—Mitoxantrone—lymphatic system cancer	0.00814	0.00814	CcSEcCtD
Fenoldopam—Haemoglobin—Carmustine—lymphatic system cancer	0.00813	0.00813	CcSEcCtD
Fenoldopam—Oliguria—Methotrexate—lymphatic system cancer	0.00809	0.00809	CcSEcCtD
Fenoldopam—Haemorrhage—Carmustine—lymphatic system cancer	0.00809	0.00809	CcSEcCtD
Fenoldopam—Body temperature increased—Teniposide—lymphatic system cancer	0.00807	0.00807	CcSEcCtD
Fenoldopam—Abdominal pain—Teniposide—lymphatic system cancer	0.00807	0.00807	CcSEcCtD
Fenoldopam—Sweating—Mitoxantrone—lymphatic system cancer	0.00803	0.00803	CcSEcCtD
Fenoldopam—Dyspnoea—Fludarabine—lymphatic system cancer	0.008	0.008	CcSEcCtD
Fenoldopam—Constipation—Fludarabine—lymphatic system cancer	0.00768	0.00768	CcSEcCtD
Fenoldopam—Bradycardia—Mitoxantrone—lymphatic system cancer	0.00765	0.00765	CcSEcCtD
Fenoldopam—Haemoglobin—Mitoxantrone—lymphatic system cancer	0.00756	0.00756	CcSEcCtD
Fenoldopam—Haemorrhage—Mitoxantrone—lymphatic system cancer	0.00752	0.00752	CcSEcCtD
Fenoldopam—Flushing—Carmustine—lymphatic system cancer	0.00751	0.00751	CcSEcCtD
Fenoldopam—Body temperature increased—Fludarabine—lymphatic system cancer	0.0071	0.0071	CcSEcCtD
Fenoldopam—Diarrhoea—Teniposide—lymphatic system cancer	0.00699	0.00699	CcSEcCtD
Fenoldopam—Chest pain—Bleomycin—lymphatic system cancer	0.00687	0.00687	CcSEcCtD
Fenoldopam—Back pain—Carmustine—lymphatic system cancer	0.00681	0.00681	CcSEcCtD
Fenoldopam—Back pain—Vincristine—lymphatic system cancer	0.0065	0.0065	CcSEcCtD
Fenoldopam—Vomiting—Teniposide—lymphatic system cancer	0.00649	0.00649	CcSEcCtD
Fenoldopam—Headache—Teniposide—lymphatic system cancer	0.0064	0.0064	CcSEcCtD
Fenoldopam—Back pain—Mitoxantrone—lymphatic system cancer	0.00633	0.00633	CcSEcCtD
Fenoldopam—Hypotension—Bleomycin—lymphatic system cancer	0.00615	0.00615	CcSEcCtD
Fenoldopam—Diarrhoea—Fludarabine—lymphatic system cancer	0.00614	0.00614	CcSEcCtD
Fenoldopam—Nausea—Teniposide—lymphatic system cancer	0.00607	0.00607	CcSEcCtD
Fenoldopam—Chest pain—Carmustine—lymphatic system cancer	0.00599	0.00599	CcSEcCtD
Fenoldopam—Anxiety—Carmustine—lymphatic system cancer	0.00597	0.00597	CcSEcCtD
Fenoldopam—Dyspnoea—Bleomycin—lymphatic system cancer	0.00587	0.00587	CcSEcCtD
Fenoldopam—Vomiting—Fludarabine—lymphatic system cancer	0.00571	0.00571	CcSEcCtD
Fenoldopam—Headache—Fludarabine—lymphatic system cancer	0.00562	0.00562	CcSEcCtD
Fenoldopam—Tachycardia—Carmustine—lymphatic system cancer	0.00561	0.00561	CcSEcCtD
Fenoldopam—Chest pain—Mitoxantrone—lymphatic system cancer	0.00557	0.00557	CcSEcCtD
Fenoldopam—Anxiety—Mitoxantrone—lymphatic system cancer	0.00555	0.00555	CcSEcCtD
Fenoldopam—Hypotension—Carmustine—lymphatic system cancer	0.00537	0.00537	CcSEcCtD
Fenoldopam—Nausea—Fludarabine—lymphatic system cancer	0.00533	0.00533	CcSEcCtD
Fenoldopam—Hyperhidrosis—Vincristine—lymphatic system cancer	0.0053	0.0053	CcSEcCtD
Fenoldopam—Tachycardia—Mitoxantrone—lymphatic system cancer	0.00521	0.00521	CcSEcCtD
Fenoldopam—Body temperature increased—Bleomycin—lymphatic system cancer	0.0052	0.0052	CcSEcCtD
Fenoldopam—Insomnia—Carmustine—lymphatic system cancer	0.0052	0.0052	CcSEcCtD
Fenoldopam—Hyperhidrosis—Mitoxantrone—lymphatic system cancer	0.00516	0.00516	CcSEcCtD
Fenoldopam—Hypotension—Vincristine—lymphatic system cancer	0.00512	0.00512	CcSEcCtD
Fenoldopam—Dyspnoea—Carmustine—lymphatic system cancer	0.00512	0.00512	CcSEcCtD
Fenoldopam—Hypotension—Mitoxantrone—lymphatic system cancer	0.00499	0.00499	CcSEcCtD
Fenoldopam—Insomnia—Vincristine—lymphatic system cancer	0.00496	0.00496	CcSEcCtD
Fenoldopam—Constipation—Carmustine—lymphatic system cancer	0.00491	0.00491	CcSEcCtD
Fenoldopam—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.00476	0.00476	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.0047	0.0047	CcSEcCtD
Fenoldopam—Constipation—Vincristine—lymphatic system cancer	0.00469	0.00469	CcSEcCtD
Fenoldopam—Constipation—Mitoxantrone—lymphatic system cancer	0.00457	0.00457	CcSEcCtD
Fenoldopam—Abdominal pain—Carmustine—lymphatic system cancer	0.00454	0.00454	CcSEcCtD
Fenoldopam—Body temperature increased—Carmustine—lymphatic system cancer	0.00454	0.00454	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.00448	0.00448	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.00437	0.00437	CcSEcCtD
Fenoldopam—Abdominal pain—Vincristine—lymphatic system cancer	0.00434	0.00434	CcSEcCtD
Fenoldopam—Body temperature increased—Vincristine—lymphatic system cancer	0.00434	0.00434	CcSEcCtD
Fenoldopam—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.00422	0.00422	CcSEcCtD
Fenoldopam—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.00422	0.00422	CcSEcCtD
Fenoldopam—Vomiting—Bleomycin—lymphatic system cancer	0.00418	0.00418	CcSEcCtD
Fenoldopam—Sweating—Methotrexate—lymphatic system cancer	0.004	0.004	CcSEcCtD
Fenoldopam—Diarrhoea—Carmustine—lymphatic system cancer	0.00393	0.00393	CcSEcCtD
Fenoldopam—Nausea—Bleomycin—lymphatic system cancer	0.00391	0.00391	CcSEcCtD
Fenoldopam—Dizziness—Carmustine—lymphatic system cancer	0.0038	0.0038	CcSEcCtD
Fenoldopam—Haemoglobin—Methotrexate—lymphatic system cancer	0.00376	0.00376	CcSEcCtD
Fenoldopam—Diarrhoea—Vincristine—lymphatic system cancer	0.00375	0.00375	CcSEcCtD
Fenoldopam—Haemorrhage—Methotrexate—lymphatic system cancer	0.00375	0.00375	CcSEcCtD
Fenoldopam—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.00365	0.00365	CcSEcCtD
Fenoldopam—Vomiting—Carmustine—lymphatic system cancer	0.00365	0.00365	CcSEcCtD
Fenoldopam—Dizziness—Vincristine—lymphatic system cancer	0.00363	0.00363	CcSEcCtD
Fenoldopam—Headache—Carmustine—lymphatic system cancer	0.0036	0.0036	CcSEcCtD
Fenoldopam—Vomiting—Vincristine—lymphatic system cancer	0.00349	0.00349	CcSEcCtD
Fenoldopam—Headache—Vincristine—lymphatic system cancer	0.00344	0.00344	CcSEcCtD
Fenoldopam—Nausea—Carmustine—lymphatic system cancer	0.00341	0.00341	CcSEcCtD
Fenoldopam—Vomiting—Mitoxantrone—lymphatic system cancer	0.0034	0.0034	CcSEcCtD
Fenoldopam—Headache—Mitoxantrone—lymphatic system cancer	0.00335	0.00335	CcSEcCtD
Fenoldopam—Nausea—Vincristine—lymphatic system cancer	0.00326	0.00326	CcSEcCtD
Fenoldopam—Nausea—Mitoxantrone—lymphatic system cancer	0.00317	0.00317	CcSEcCtD
Fenoldopam—Back pain—Methotrexate—lymphatic system cancer	0.00315	0.00315	CcSEcCtD
Fenoldopam—Chest pain—Methotrexate—lymphatic system cancer	0.00278	0.00278	CcSEcCtD
Fenoldopam—Hyperhidrosis—Methotrexate—lymphatic system cancer	0.00257	0.00257	CcSEcCtD
Fenoldopam—Hypotension—Methotrexate—lymphatic system cancer	0.00249	0.00249	CcSEcCtD
Fenoldopam—Insomnia—Methotrexate—lymphatic system cancer	0.00241	0.00241	CcSEcCtD
Fenoldopam—Dyspnoea—Methotrexate—lymphatic system cancer	0.00237	0.00237	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.00218	0.00218	CcSEcCtD
Fenoldopam—Body temperature increased—Methotrexate—lymphatic system cancer	0.0021	0.0021	CcSEcCtD
Fenoldopam—Abdominal pain—Methotrexate—lymphatic system cancer	0.0021	0.0021	CcSEcCtD
Fenoldopam—Diarrhoea—Methotrexate—lymphatic system cancer	0.00182	0.00182	CcSEcCtD
Fenoldopam—Dizziness—Methotrexate—lymphatic system cancer	0.00176	0.00176	CcSEcCtD
Fenoldopam—Vomiting—Methotrexate—lymphatic system cancer	0.00169	0.00169	CcSEcCtD
Fenoldopam—Headache—Methotrexate—lymphatic system cancer	0.00167	0.00167	CcSEcCtD
Fenoldopam—Nausea—Methotrexate—lymphatic system cancer	0.00158	0.00158	CcSEcCtD
